News
14d
MedPage Today on MSNFirst-in-Class Lupus Drug Aces Phase III TestA novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according to phase III ...
Bowl of Quick Cook on MSN15d
Living with the 'Cruel Mystery': Navigating the Unpredictable Journey of Lupus, Shared by Stars and ExpertsThis unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease presents unique challenges for people with it. Your body’s defense system, ...
BlackDoctor.org & AstraZeneca unite to fight cancer & lupus. Hear inspiring survivor stories and learn about early detection ...
Simple blood test offers new hope to lupus patients. Up to 69,000 people in the UK have lupus, a chronic autoimmune condition. Storm Newton. PA Health Reporter. Friday 09 May 2025 00:01 BST.
AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK drugmaker plows billions into the growing area of cell therapy called ...
The antinuclear antibody test, commonly called ANA, shows positive results in about 95% of lupus patients. However, this test also produces positive results in many healthy individuals and those ...
Word In Black According to Dr. Keith Elkon, lupus impacts Black women at three times the rate of white women, and ...
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...
New Zealand-born Japanese international Warner Dearns is reversing the rugby sabbatical route by taking a year off from his Toshiba Brave Lupus club to have the 2026 season of DHL Super Rugby Pacific ...
After that nightmare staff meeting on Feb. 12, 2010 at which three of his colleagues were killed and three others wounded, Ng ...
One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.
Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results